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ABSTRACT
Objectives: to compare between transurethral en-block Ho-yag laser enucleation and
transurethral resection for papillary bladder cancer.
Methods: this is a prospective randomized study, carried out at urology department,
zagazig university hospitals during the period from 15/7/2017 to 15/2/2018. Aimed
to compare between laser en-block enucleation and transurethral resection for
papillary bladder cancer as regard intraoperative outcomes (perforation, obturator
jerk and bleeding) and post-operative outcomes (wash time, catheter time, hospital
stay and blood transfusion).
Results: we studied 52 patients randomized in two groups, group for Ho-yag laser
en-block enucleation and group for monopolar TURBT. We found that Ho-Yag laser
was superior to TURBT in term of intraoperative complications and postoperative.
Conclusions: Laser enucleation appear to be reliable procedure with many
advantages over monopolar TURBT, despite it need longer resection time, it reduces
intra-operative complications and post-operative complications, it allow to remove
the tumour completely from tumor’s bed so decrease the probability of local
persistence of malignant tissue.
Key words: comparison between Ho-yag laser en-block enucleation and monopolar
TURBT in NMIBC

INTRODUCTION
he most prevalent cancer of the urinary
tract is tumor of the urinary bladder. It
includes a broad range of histological
heterogeneous tumor types arising mostly
from the urothelium lining of the urinary
bladder and ureters, including bladder
transitional
cell
carcinoma
(BTCC),
squamous cell carcinoma, adenocarcinoma,
and other less frequent lesions. More than
90% of the bladder tumors are diagnosed as
BTCC and the majority of BTCC (70%) are
recognized as papillary
bladder cancer.
(Stage pTa, T1) [1] .Cystoscopy is
recommended in all patients with symptoms
suggestive of Bladder Cancer. It cannot be
replaced by cytology or by any other noninvasive test [2]. Cystoscopy combined with
urine cytology is routinely used for the
diagnosis of BTCCs [3]. The goal of TURBT
in Ta, T1 Bladder Cancer is to make the
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correct diagnosis and completely remove all
visible lesions. It is a crucial procedure in the
diagnosis and treatment of Bladder cancer.
TURBT should be performed systematically
in individual steps. The strategy of resection
depends on the size of the lesion. Separate
resection of larger tumors provides good
information about the vertical and horizontal
extent of the tumor and helps to improve
resection completeness [4].
PATIENT AND METHOD
1) Technical design:
This is a prospective randomized study,
Carried out at Urology Department, Zagazig
University hospitals during the period from
15/7/2017 to 15/2/2018. Aimed to compare
between laser en-block enucleation and
monopolar TUBRT for papillary bladder
cancer as regard intraoperative outcomes
(perforation , obturator jerk and bleeding )
and post-operative outcomes ( wash time
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1

Zagazig University Medical Journal, Vol. 27 [2021], Iss. 2, Art. 16

Doi: 10.21608/zumj.2019.6903.1005









2)
❖
❖
•
•
•
•
❖
•
•

1.

,catheter time , hospital stay, blood
transfusion ,residual ).
Inclusion criteria:
Patients with bladder mass proven by
Ultrasonography and pelvic CT and scheduled
for Diagnostic cystoscopy and TURBT.
Single lesion.
Tumor size (1 – 3 cm).
Exclusion criteria:
Recurrent tumor.
Any contraindication to monopolar TURBT
(pace maker, uncontrolled coagulopathy etc.).
Other bladder or urethral pathologies (e.g.
urethral stricture, bladder stone etc.).
Tumor with histopathologic result showing
T2.
Operational design
Patients’ evaluation:
History taking and physical examination.
Lab investigations:
Urine analysis.
CBC.
Coagulation profile.
Renal and liver profile.
Radiologic investigations
KUB & US.
Pelvi-abdominal CT with i.v contrast if serum
creatinine less than 2 mg/ml. (if more than 2
mg/ml CT cystogram).
Informed consent
All patients were informed about their
surgical condition and different modalities of
treatment with possible side effects. Patients
who refused to participate were excluded
from our study. Written informed consent was
obtained from all participants and the study
was approved by the research ethical
committee of Faculty of Medicine, Zagazig
University. The work has been carried out in
accordance with The Code of Ethics of the
World Medical Association (Declaration of
Helsinki) for studies involving humans.
Randomization
Patients were randomized using 1:1
ratio in both group A and B respectively.
The procedure:
In both groups [ Ho-Yag laser En-block
enucleation (group A) and in monopolar
TURBT (group B) ]
Procedure in both groups was done by single
experienced surgeon.
Ashraf M., et al..
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2. Anesthesia, all patients received regional
anesthesia.
3. Patient positioning in lithotomy
position.
4. Examination under anaesthesia.
5. Diagnostic urethrocystoscopy.
Diagnostic urethrocystoscopy made by
cystoscope, started by inspection of urethral
meatus then intraurethral injection of
lubricant gel, straightening the penis,
cystoscope inserted into fossa navicularis.
Inspection of urethral mucosa, external
sphincter,
prostatic
urethra
with
verumontanum then bladder neck. Then
inspection of urinary bladder mucosa in all
walls, checking ureteric orifice site, shape and
if any abnormalities, inspect urine efflux.
Description of bladder masses
Site, Size, Shape, number, Surrounding
mucosa, presence of calcification.
A. In Ho-YAG en-block resection : ( group A )
After cystoscopy, and adequate mapping
of the bladder is done, we introduce the
resectoscop with the laser working element
adapted with 2 metal fenestrated spatula.
Isotonic saline is used during the procedure.
We use the 100 w sphinx machine as source
for Ho-Yag laser. Laser power is set as Power
1.5 - 2 joules, Frequency 17-20 pulse per
minute and Pulse duration 350-550
microsecond on the 1000 micrometre laser
fibre.
A marking is done using Ho-Yag laser
in coagulation (defocused mode) around the
bladder mass including the tumor and 2 – 5
mm of surrounding normal mucosa. This
helps in orientation during the procedure.
Then an incision is made in the bladder
mucosa using the laser fibre in cutting
(contact) mode following the marking around
the mass.
Using the laser energy to cut and create
plan under detrusor muscle, tension is made
on the tumor using metal spatula, to create
counter traction a plan is created beneath the
bladder mass and the tumor bed. This plan is
gradually developed and followed all around
the tumor till the mass is completely detached
from the bladder wall. Bleeding is coagulated
using laser fibre is defocused (coagulation)
mode. Tumor is retrieved either with
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irrigation of the bladder using (Elliks)
evacuator, using 26 French nephroscope and
its grasper or using basket.
B. In Monopolar TURBT resection : ( group B )
After localizing the tumor, resection
started by placing resecting loop behind the
tumor, then retraction the resecting loop
towards resectoscop shaft, taking the tumor in
fraction, started from up to the base of tumor,
after resecting all the tumor, deep sample
taken from tumor bed to rule out deep muscle
invasion.
After resection:
Cup biopsy was taken from the tumor’s bed in
group A and deep cut by monopolar in group
B.
Examination
under
anaesthesia
(PR
examination).
Catheter fixation and irrigation: triple way
Foley cath was fixed in all patients [20-22 F]
with continuous irrigation for 6 hours post
operatively.
Immediate instillation of mitomycin c (40mg
in 40 ml saline) was done in all patients
during 6 hours post-operative.
Specimens sent in 2 containers in each group,
in group A (1 container containing the tumor
in 1 piece and 1 container containing tumor

bed ) and in group B ( 1 container containing
tumor chips and 1 container containing tumor
bed ).
Postoperative operative care:
Observing vital sign.
Pain control.
Early mobilization.
Observe the Color of the bladder irrigation.
Foly’s catheter removed on the day of
discharge.
Follow up plan
1. First visit after one week of discharge:
Checking results of histopathology.
Preparation for check cystoscopy ( routine
LAB investigation and U.S imaging to be
done few days before scheduled check-up
cystoscopy ).
2. Check-up cystoscopy after 4-6 weeks.
STATISTICAL ANALYSIS
Data collected throughout history, clinical
examination, radiological investigations,
laboratory investigations, intra-operative
complications
and
post-operative
complications, analysed using Microsoft
Excel software. Data were then imported into
Chi-square Analysis program version 2.5 for
analysis.

Table (1): Operative and catheter time and hospital stay.
Group A
(N=26)

Group B
(N= 26)

Mean±sd

Mean±sd

Total operative time (min)

48.38±10.852

27.50±7.90

Resection time /Enucleation
(min)
Wash time
(hour)
catheter time (day)

40.96±10.200

20.54±6.993

6.2±1.62

7.65±2.48

2.96±1.84

4.04±1.90

Hospital stay (day)

1.19±0.49

1.88±1.21

Variable
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P value

<0.001
(HS)
<0.001
(HS)
0.016
(S)
0.04
(S)
0.009
(HS)
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Table (2) Pre-0perative and post-operative haemoglobin level.
Group

Preoperative
haemoglobin

Postoperative
haemoglobin

P value

Group A
mean±sd g/dl

14.65±0.99

14.26±1.01

0.165
(NS)

Group B
mean±sd g/dl

14.36±0.96

13.57±1.9

0.064
(NS)

Table (3): Intra-operative & post-operative complications.
Variable

Intraoperative
complications

Postoperative
complications

Group

P value

Obturator jerk

Group A
0

0.0%

Group B
5
19.2%

perforation

1

3.8%

3

11.5%

Blood transfusion

0

0.0%

1

3.8%

0.04
(S)

0.07
(NS)

Table (4): Tumor bed result.
Group
Biopsy from tumor bed after finishing
resection / enucleation
Group A
N= 26
Free
26
Positive

0

RESULT
This study was done at zagazig university ,
we assessed 62 patients of eligibility , 5 of
them excluded ( 3 cases converted to
monopolar in group A after starting en-block
laser enucleation ( large tumor more than 3cm
) and 2 cases refused to participate ) , 57
randomly allocated in two groups , 28 in
group A ( laser enucleation ) and 29 in group
B ( monopolar TURBT ) , 1 case lost follow
up and 1 case it’s pathology result came T2 in
group A and 2 cases lost follow up and 1 case
it’s pathology result came T2 in group B. so
26 cases analyzed in each group.
Both the total operative time and
resection/enucleation time were significantly
statically longer in group A compared to
Ashraf M., et al..
https://digitalcommons.aaru.edu.jo/zumj/vol27/iss2/16

P Value

100.0%

Group B
N=26
23

88.5%

0.0%

3

11.5%

0.07
(NS)

group B ( P value <0.001 and P value <0.001
respectively ) (table 1 ).
On the other side the wash time was shorter in
group A compared to group B ( P value 0.016
) , also the catheter time was shorter in group
A compared to group B ( P value 0.04 ) (table
1).
The hospital stay in group A was significantly
shorter compared to group B ( P value 0.009 )
(table 1).
No significant hemoglobin drop observed in
both groups between pre-operative and postoperative period ( P value 0.165 in group A
and P value 0.064 in group B ) (table 2) ,
blood transfusion was needed only in 1 case
in group B ( table 3 ).
No obturator jerk observed in group A while
seen in 5 cases in group B , perforation
206 | P a g e
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happened in 1 case in group A and in 3 cases
in group B
( P value 0.04 ) (table 3).
After resection in group B there were 3 cases
with positive tumor bed while in group A
tumor bed was free in all cases after tumor
enucleation (table4).
DISCUSSION
Transurethral resection of urinary bladder (
TURBT ) is the most common and most
important procedure which all urologist
should be familiar with it because of its
importance in diagnosis and treatment of
urinary bladder cancer , it is a gold standard
procedure in staging all types of urinary
bladder cancer, different technique can be
used during TURBT , the most commonly
technique used is monopolar resection ,
monopolar TURBT
has good result in
treatment of bladder cancer and less time
needed during operation and good hemostatic
effect during resection but at the same time
there is undesired complications of this
technique which can be avoided by using new
resection techniques.
Even though conventional TURBT is the gold
standard procedure for making diagnosis and
treating non-muscle invasive bladder cancer,
however this technique has many limitations
including:
The standard TURBT technique involves
piecemeal resection of the tumour, which
liberates tumour cells into the bladder and
may explain the high recurrence rates (50–
70%) for superficial bladder cancer [5].
At re-resection (depending on tumor location
and number), residual tumor was observed in
up to 76% of patients [6].
Obturator jerk
Resection of tumors on the lateral wall can
stimulate the obturator nerve, resulting in
sudden leg adduction which can force the
resectoscop to produce bladder perforation
[7].
Peri-Operative outcomes
In the current study the resection time was
significantly longer in en-block enucleation
compared to TURBT, which may be
explained by the fact that the study was done
for relatively large tumors and bleeding
control took longer time in en-block
enucleation. In contrast, Song Xishuang and
Ashraf M., et al..
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co-workers could not find significant
difference in operative time between TURBT
and Ho-Yag laser resection. However, in
their study the Ho-Yag laser was used to
resect rather than to enucleate the tumors, also
the mean tumor size ranged from 15-18mm.
[7].
In this study at the end of cystoscopy a cup
biopsy was taken from the tumor bed and in
group A negative biopsy was obtained in all
cases compared to group B and this was with
high significance. This result was similar to
the study done by Saito et al. [8] as they
found that laser en-block resection method
had the advantage of complete and accurate
removal of superficial urinary bladder tumor.
CONCLUSION
Laser enucleation appear to be reliable
procedure with many advantages over
monopolar TURBT , despite it need longer
resection time, it reduce intra-operative
complications
and
post-operative
complications, it preserve tumor histological
architecture and it allow to remove the tumor
completely from tumor’s bed so decrease the
probability of local persistence of malignant
tissue.
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